|
WO2021074808A1
|
|
Pharmaceutical composition comprising sacubitril and valsartan and process for preparation thereof
|
|
EP3792271A1
|
|
A process for the preparation of brivudine
|
|
WO2020161654A1
|
|
A process for the preparation of trametinib acetic acid solvate
|
|
WO2019229572A1
|
|
An improved process for the preparation of eltrombopag olamine and its intermediates
|
|
WO2019186520A1
|
|
A process for the preparation of lifitegrast
|
|
WO2019180547A1
|
|
A process for the preparation of vigabatrin
|
|
US2020316043A1
|
|
Pharmaceutical composition comprising clevidipine and process for preparation thereof
|
|
WO2019116169A1
|
|
Canagliflozin substantially free of hydroperoxide impurity
|
|
WO2019106490A1
|
|
A process for the preparation of cariprazine hydrochloride
|
|
EP3681880A1
|
|
Process for preparing crystalline tipiracil hydrochloride
|
|
WO2019016637A1
|
|
A process for the preparation of deferasirox
|
|
WO2018229580A1
|
|
An improved process for the preparation of cefovecin sodium
|
|
WO2018220504A1
|
|
A process for the preparation of docosanol
|
|
WO2018207120A1
|
|
A process for the preparation of 4-fluoro-2-methoxy-5-nitroaniline
|
|
WO2018130942A1
|
|
A process for the preparation of phenoxybenzamine
|
|
EP3544590A1
|
|
Naloxegol oxalate and solid dispersion thereof
|
|
WO2018060870A1
|
|
Pharmaceutical composition of ivermectin and process for preparation thereof
|
|
US2019185230A1
|
|
Disc Shaped Device to Prevent Abrasion
|
|
US2019169152A1
|
|
Process for the preparation of DL-proline co-crystal of Dapagliflozin
|
|
WO2017153939A1
|
|
Pharmaceutical composition comprising canagliflozin, process of preparation and use thereof
|
